Innovative Parkinson's drugs presented to Tatarstan leader Minnikhanov

Innovative medicines developed by scientists at a Kazan university were presented to Rustam Minnikhanov, head of the Republic of Tatarstan, as part of an exhibition at the TAYM forum. Kazan State Medical University rector Airat Farrakhov and Institute of Pharmacy director Ruslan Mustafin presented the projects, which have significant commercial potential and aim at import substitution.

Two key products were shown. The first is a nasal spray based on levodopa, featuring an innovative delivery system for treating Parkinson's disease. The second is pediatric propranolol mini-tablets, developed in close partnership with the region's leading pharmaceutical manufacturer, OJSC Tatkhimfarmpreparaty. The product has no direct market analogues in Russia and is at the final stage of preclinical studies.

Farrakhov thanked industrial partners for their comprehensive support and effective joint development of the projects, saying this cooperation opens new prospects for the domestic pharmaceutical industry.